Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Aquapharm Bio-Discovery Ltd completes £1.25M funding and is first to locate in the new European Centre for Marine Biotechnology

11.08.2005


Aquapharm Bio – Discovery Ltd (Aquapharm), a leading UK marine biotechnology company developing, amongst other things, anti-infective drug candidates from marine natural products, is pleased to announce the completion this month of its latest round of financing.

The investment of £344000 by E-Synergy Ltd and the Scottish Enterprise Co-Investment Fund completed the £1.25 million package by adding to a recent earlier investment of £350000 (£175,000 each) by NESTA (the National Endowment for Science, Technology and the Arts) and Argyll & the Islands Enterprise (AIE), and thereby paving the way for a future equity investment of £253,400 and grants of up to £300000 from AIE.

Aquapharm was formed in 2000 by Dr Andrew Mearns Spragg & Dr Kathryn Fraser, and is one of the first UK marine biotechnology companies. This funding round has allowed it to expand into new bespoke laboratory facilities within the European Centre for Marine Biotechnology (ECMB), which is situated beside the sea near Oban in Argyll. The Company currently employs a team of 9 full-time staff and has recently strengthened the management team with the addition of three new non-executive directors.



Dr Jo Oliver who through a previous association with SAMS has a knowledge of who is doing what in marine biotechnology, and Mr Colin Garvie, who has extensive financial and commercial experience gained over 25 years which included working with one of the UK’s largest Venture Capital firms, will join long standing non-ex chairman Dr Ron James who provides commercial and deal making support to the board. The incoming investor director, Dr John White, a successful entrepreneur in his own right and a member of E-Synergy’s angel syndicate, will fly his own light aircraft to the local airport to attend board meetings and brings in a wealth of commercial skills.

Dr Andrew Mearns Spragg, the CEO of Aquapharm said “Completing this investment will allow the Company to increase its research programmes including expansion of the project screening of novel marine organisms for new antibiotics. Already, a new anti-infective molecule has been identified that targets multi-drug resistant infections such as MRSA. There is a definite need for new types of antibiotics to combat bacterial infections that have become resistant to most of our available antibiotics” Aquapharm’s other research programmes are the development marine sources of functional foods & organic carotenoid pigments.

The Company also offers access to its growing collection of marine organisms, some of which are new to science, and most of which were collected from Scottish waters, some of the most prolific and cleanest of marine environments in the world, to pharmaceutical and biotech companies that have assays to screen for other drugs, industrial enzymes etc.

Lachie Beaton, a spokesman for AIE said “We are delighted that Aquapharm has completed its funding package.” The ECMB was established along side SAMS to foster commercial development of marine science and build on the world-class academic marine biology we have here. It fits with the objectives of the Smart Successful Scotland programme”. John White added, “We are happy to have made this investment. The work the Company is doing is exciting and we believe, in time, we will make a good return. It is the first investment we have done with the Scottish Co-Investment fund, but I hope it will not be the last.

Joseph Meaney | alfa
Further information:
http://www.aquapharm.co.uk

More articles from Ecology, The Environment and Conservation:

nachricht How does the loss of species alter ecosystems?
18.05.2017 | Deutsches Zentrum für integrative Biodiversitätsforschung (iDiv) Halle-Jena-Leipzig

nachricht Excess diesel emissions bring global health & environmental impacts
16.05.2017 | International Institute for Applied Systems Analysis (IIASA)

All articles from Ecology, The Environment and Conservation >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

How herpesviruses win the footrace against the immune system

26.05.2017 | Life Sciences

Water forms 'spine of hydration' around DNA, group finds

26.05.2017 | Life Sciences

First Juno science results supported by University of Leicester's Jupiter 'forecast'

26.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>